The sequence analysis of the 5 ends of cDNAs prepared using the anchor ligation method has revealed that most of the full-length cDNAs have an additional dGMP at their 5 end that is absent in the corresponding genome sequence. Using model RNA transcripts with cap analogues possessing 7-methylguanosine and adenosine, the base of the added nucleotide has been shown to be complementary to the base of the cap analogue, suggesting that the cDNAs possessing an additional dGMP are derived from intact mRNAs with the cap structure. On the other hand, cap-free RNA did not produce cDNA with an extra dGMP. These findings suggest that we can determine whether or not the cDNA starts from the capped site sequence of mRNA based on the presence or absence of an additional dGMP at the 5 end of the cDNA synthesized using the anchor ligation method. This approach will be useful to determine the capped site sequence of mRNA, thus, to identify transcription start sites.
Recent enormous sequencing efforts have led to the completion of the whole genome sequences of various kinds of organisms. The next challenge is to identify the promoter region of each gene on the genome. A robust way to identify the promoter region is to determine a transcription start site by sequencing a full-length cDNA containing the capped site sequence of mRNA. Several methods have been developed to synthesize the full-length cDNA starting with the capped site sequence. The methods are classified into two categories based on the principle used. One is based on the addition of an oligonucleotide to cDNA 1−7 and another on replacement of the cap structure of mRNA by an oligonucleotide.
8,9
Although full-length cDNA synthesized by any method can be used to determine the capped site sequence of mRNA, there is a common problem with conventional methods. The truncated products derived from degraded mRNA and premature termination of cDNA synthesis obscure the reliability of the capped site sequence so that we can not guarantee that the 5 -end sequence of the obCommunicated by Michio Oishi * To whom correspondence should be addressed. Tel. +81-4-2995-3100 (Ext. 2568), Fax. +81-4-2995-3132, E-mail: seishi@rehab.go.jp tained cDNA is the capped site. Reverse transcriptase has been known to possess terminal deoxynucleotidyl transferase (TdTase)-like activity that causes the cap-dependent addition of multiple cytosine residues to the 3 end of the first-strand cDNA during cDNA synthesis. 10 One residue of cytosine (dC) was preferentially added under the buffer conditions used in ordinary reverse transcriptase reactions, but three or four dCs were added in MnCl 2 -containing buffer.
11 The understanding of this mechanism might be useful to determine whether a given cDNA has a capped site sequence or not.
In order to confirm the cap-dependent dC addition to the 3 end of the first-strand cDNA, we determined the 5 -terminal sequences of cDNAs synthesized using the anchor ligation method. 4−6 We chose human eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) mRNA as a target template as it is an abundant transcript expressed in many cells including the human retinal pigment epithelium cell line ARPE-19 used in this experiment. The procedure followed was one described in the original papers. 5, 6 The first-strand cDNA was synthesized with a primer complementary to the 3 end of EEF1A1 mRNA. The 5 phosphorylated and 3 blocked + RNA (0.5 µg) was annealed with an EEF1A1-specific primer (5 -AAGCG GCCGC CATTT AACTT TTTTA ATGGG TCTC-3 , complementary to the 3 end of EEF1A1 mRNA), and then the first-strand cDNA was synthesized at 55
• C for 1 hr in a 20-µl reaction containing 200 U of reverse transcriptase (SuperScriptIII TM , Invitrogen) and 40 U of ribonuclease inhibitor (TaKaRa). The reaction conditions were followed by the manufacturer's protocol. An anchor oligonucleotide (5 -TATAG TGAGT CGTAT TAGAA TTCCC -3 , purchased from Genset), in which the 5 end was phosphorylated and a 3 end was blocked with NH2, was ligated to the RNA/cDNA heteroduplex. Ligation reactions were carried out at 20
• C for 15 hr in a 50-µl reaction containing 200 U of T4 RNA ligase (TaKaRa) using the buffer conditions of the manufacturer's protocol. PCR amplification was performed using an anchor primer (5 -GGGAA TTCTA ATACG ACTCA CTATA-3 ) and the EEF1A1-specific primer under the following conditions: pre-incubation at 96
• C for 1 min; 30 sec at 96
• C, 30 sec at 51 • C, 2 min at 72
• C, for 30 cycles. The PCR product isolated from the main band on an agarose gel was inserted between EcoRI and Not I of a vector pKA1. 9 The 5 sequence of cDNA was determined with a capillary DNA sequencer (ABI PRISM 3100 genetic analyzer, PE Biosystems Japan) using a BigDye Terminator Cycle Sequencing FS Ready Reaction Kit. Underlined letters represent inserted nucleotides.
oligonucleotide anchor was ligated to the mRNA/cDNA heteroduplex using T4 RNA ligase. PCR amplification was carried out using an anchor primer and an EEF1A1-specific primer. After the PCR products were inserted into a vector, cDNA clones were randomly picked up and their 5 sequences were determined.
The sequencing of 96 cDNA clones showed that 82 clones contained a sequence derived from EEF1A1 mRNA, in which 80 clones had a capped site sequence ( Table 1 ). The human EEF1A1 gene is a member of the 5 -terminal oligopyrimidine tract gene family. There are five thymidines (Ts) in the genome sequence, but cDNAs showed variation in this number. 8, 9 In this experiment, 68 out of 80 cDNAs had five Ts, but the number of Ts in the remainder ranged from 4 to 9, as reported previously.
The most notable observation is the insertion of one dG between the cDNA and the anchor (67 clones, 81.7%). Nine clones had one dA insertion, two clones had dT, and one clone had dC and dGdG. Truncated clones had no additional nucleotide at the 5 end. These results suggest that most of the full-length cDNA clones have an extra dG at their 5 end.
The preferential addition of dG has been thought to occur in a cap-dependent manner. 10, 11 To confirm this hypothesis, we planned to synthesize cDNA using model RNA with a cap analogue as a template. The above experiment gave us the EEF1A1 full-length cDNA having an extra dG preceded by a T7 RNA polymerase promoter, which is capable of preparing EEF1A1 RNA by in vitro transcription. If a cap analogue, 7-methylG(m 7 G)-5 -ppp-5 -G or A-5 -ppp-5 -G, is added to the reaction mixture, we can prepare the in vitro transcribed RNA with m 7 G-or A-capped terminus. The in vitro capped RNA as well as cap-free RNA was used as a template for cDNA synthesis, and then anchor ligation followed by PCR amplification was performed. Table 2 shows the results of sequence analysis of PCR products. Most cDNA clones prepared from cap-free RNA had no nucleotide insertion. On the other hand, m 7 G-capped and A-capped RNAs produced dG-and dA-inserted cDNA clones, respectively. The cDNA with no insertion may result from uncapped RNA that failed to incorporate the cap analogue during the in vitro transcription. These results clearly show that the insertion of an extra nucleotide depends on the presence of the cap and the base of the inserted nucleotide is complementary to that of the cap.
The above two experiments were carried out using the EEF1A1 mRNA as a template. To confirm that the dG addition is not specific to the EEF1A1 mRNA, we inspected the 5 terminal sequences of cDNA clones synthe- The EEF1A1 cDNA used for in vitro transcription was prepared by cloning the EcoRI-EcoRV fragment of the PCR product described in Table 1 to the EcoRI-EcoRV site of pKA1-HP00155 carrying EEF1A1 full-length cDNA. 9 The in vitro transcription reaction was carried out using an in vitro transcription kit (MEGAscript TM , Ambion) in the presence or absence of a cap analogue, m 7 G-5 -ppp-5 -G or A-5 -ppp-5 -G (Ambion). The reaction conditions were according to the manufacturer's protocol. The capped RNAs were used for cDNA synthesis. The protocols for cDNA synthesis, anchor ligation, and PCR were identical to the one described in Table 1 . Underlined letters represent inserted nucleotides. Note that the EEF1A1 full-length cDNA possessing one dG at the 5 end was used for in vitro transcription to incorporate a cap analogue NpppG.
sized from six kinds of mRNAs using the anchor ligation method. Table 3 shows that every clone has one dG at its 5 terminus. Their capped site sequences agreed with those of the full-length cDNA clones that were synthesized using the oligo-capping method. 9 These results suggest that the addition of dG is independent of the mRNA sequence.
The present results show that cDNA clones prepared using the anchor ligation method have a cap-dependent nucleotide insertion at their 5 terminus. Model experiments using in vitro transcribed RNAs with the cap analogue revealed that the nucleotide complementary to the base of the cap structure is preferentially inserted. There are two possible processes by which the insertion of the additional nucleotide occurred: the first-strand cDNA synthesis and the anchor ligation. The ligation process can be excluded because no insertion was observed in the cDNAs prepared from a cap-free RNA template. The addition of multiple dCs to the 3 end of the first-strand cDNA, corresponding to the addition of dGs to the 5 end of cDNA, has been reported and applied to synthesize full-length cDNA, called the CapFinder method.
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According to Schmidt and Mueller, 11 a single dC was preferentially added under the ordinary conditions used in the first-strand cDNA synthesis and three to four dCs were added in the presence of MnCl 2 . These observations suggested that the addition of dC to the 3 end of cDNA would result from TdTase-like activity of reverse transcriptase.
Recently, Chen et al. 12 investigated the TdTase-like activity of reverse transcriptase using an RNA/DNA heteroduplex as a substrate and observed that a single nucleotide, preferentially dA, was added to the 3 end of the DNA strand. This experiment corresponds to our approach using cap-free RNA in which a blunt-ended RNA/cDNA heteroduplex is a substrate. However, we have rarely observed such an addition of a nucleotide using our method. This means that, with our method, we can neglect the addition of a nucleotide to the bluntended RNA/cDNA produced from the truncated mRNA, 
GCCCTTTCCTCAGCTGCCGCCAAGGTGCTCG

Vimentin
gggtccagtcCtctgccactctcgctccgaggtccccgcg GCTCTGCCACTCTCGCTCCGAGGTCCCCGCG
The genome sequence was indicated in lower case, in which the transcription start sites obtained by the oligo-capping method are shown in upper case. As there were some variations in the transcription start site of each gene as well as EEF1A1, the most frequent sequence is shown. The cDNA was synthesized at 42
• C using reverse transcriptase (SuperScriptII TM , Invitrogen) and a gene-specific primer complementary to the 3 end of each mRNA. The other conditions were as shown in Table 1 .
suggesting that the truncated cDNA has no additional nucleotide at the 5 end. Indeed, we have scarcely observed a truncated cDNA having a non-templated additional nucleotide insertion. On the other hand, when the capped RNA was used as a template, a cap-dependent nucleotide addition was always observed. This addition seems to be catalyzed by the TdTase-like activity of reverse transcriptase rather than by inherent reverse transcriptase activity, because the cap is in the reverse orientation from the other nucleotides. Such preferential nucleotide addition can be explained by a local high concentration of the nucleotide complementary to the base of the cap. When m 7 G-capped mRNA was used, the insertion of dA was frequently observed. This may result from concentration of dTTP near the capped site by G-T pairing.
The results of the present study imply that if the 3 end of the first-strand cDNA can be properly trapped we can determine whether the cDNA starts from the capped site or not based on the presence or absence of an additional dG at the 5 end of the cDNA. Especially, if the whole genome sequence has already been determined, it is easy to identify an extra dG by comparing the 5 end sequence of the cDNA with the genome sequence. We cloned several cDNAs with the known capped site sequence and confirmed that all has an extra dG not including in the genome sequence. Conversely, the cDNA clones not starting with dG were attributed to the truncated mRNA not having the cap structure. Strictly speaking, the present approach is not applicable to the cDNA derived from mRNA whose transcription starts after dG in the genome. Almost all cDNAs starting with dG, however, can be practically regarded as a full-length cDNA possessing the capped site sequence, because when we used high-quality mRNA, the main PCR products most likely originating from capped RNA started with dG and there were few truncated cDNA clones with dG at the 5 end.
The present approach to identifying the capped site sequence is effective only when the method does not include a process accompanying an artificial dC addition during trapping of the 3 end of the cDNA. For example, dC tailing should be avoided in the homopolymer tailing method. The use of a homopolymer primer may generate misanealing products lacking the 5 end of the cDNA during a PCR process. To overcome the defect of the tailing method, several methods have been developed such as CapFinder, 10 CapSelect, 11 and the single-stranded linker ligation method. 13 These methods probably cause modification of the 5 end of cDNA by adding artificial dGs derived from a linker oligonucleotide so that it is impossible to determine whether the dG at the 5 end results from cap-dependent dG addition or the linker sequence. Thus, the anchor ligation method is preferable to synthesize the cDNA for determining the capped site sequence. Our next challenge is to develop an effective method for preparing a full-length cDNA library based on the anchor ligation method for massive analysis of capped site sequences.
